Overdue loans of Armenia’s banks drop to 24.4 bln drams in October

YEREVAN, December 3. /ARKA/. Overdue loans of Armenian commercial banks fell by 6.3% in October compared to September, to 24.4 billion drams or 1.44% of total lending, ArmStat reported.

About 96.7% of this or about 23.6 billion drams were short-term loans.

Extended loans amounted to 86.2 billion drams in the period, a reduction of 4.3%, of which 75.6 billion drams were short-term loans.

According to statistical data, loan investments of all banks amounted to over 1,583.8 billion drams in October, an increase of 0.3% over the month. Of that amount about 990.5 million drams were loans in foreign currency.

As of October, aggregate loans of Armenia’s commercial banks were about 1,694.5 billion drams. ($1=403.91drams).  –0–

spot_img

POPULAR

US dollar, euro, and ruble drop against Armenian dram

YEREVAN, August 18. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market as of August 18, 2026, fell by 0.25 points to 365.25 drams compared to August 17.

“Solis” CJSC’s bonds listed on Armenia Stock Exchange

YEREVAN, August 18. /ARKA/. The range of companies listed on the Armenia Stock Exchange (AMX) continues to expand, contributing to the development of the capital market and creating new opportunities for businesses.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Armbanks Weekly Digest: Key Events in Armenia’s Financial Market (August 10-16)

YEREVAN, August 17. /ARKA/. Armenia's financial agenda last week focused on setting up payment and cryptocurrency infrastructure, capital market activity, and the parameters of the next stage of universal health insurance.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img